Home / Denmark / Novo Nordisk A/S
Novo Nordisk A/S
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
2 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 6, 2026 | D. E. Shaw & Co., L.P. | 0.48% | February 6, 2026 |
| February 4, 2026 | D. E. Shaw & Co., L.P. | 0.53% | February 4, 2026 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novo Nordisk A/S, source Finanstilsynet, data as at February 6, 2026, https://www.quivad.com/action/novo-nordisk-a-s